• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用ErbB2与ErbB3或ErbB4的可溶性细胞外结构域形成高亲和力的神经调节蛋白结合位点。

Formation of a high affinity heregulin binding site using the soluble extracellular domains of ErbB2 with ErbB3 or ErbB4.

作者信息

Fitzpatrick V D, Pisacane P I, Vandlen R L, Sliwkowski M X

机构信息

Genentech, Inc., Department of Molecular Oncology, South San Francisco, CA 94080, USA.

出版信息

FEBS Lett. 1998 Jul 10;431(1):102-6. doi: 10.1016/s0014-5793(98)00737-6.

DOI:10.1016/s0014-5793(98)00737-6
PMID:9684874
Abstract

ErbB2 functions as a shared signal transducing component for other ErbB receptor family members. Two of these receptors, ErbB3 and ErbB4, bind the heregulin (HRG) or neuregulin family of polypeptide growth factors. Cells expressing ErbB3 alone display a single class of low affinity HRG binding sites, whereas both high and low affinity binding sites can be measured on cells that co-express both ErbB3 and ErbB2. To assess the interaction of the extracellular domains of ErbB receptors, a series of soluble homodimeric and heterodimeric IgG fusion proteins were constructed. Heregulin binding analysis revealed that a heterodimer composed of either ErbB3 or ErbB4 with ErbB2 is sufficient for the formation of a high affinity binding state. In contrast, heterodimeric ErbB3/4-IgG, as well as homodimeric ErbB3-IgG or ErbB4-IgG, contained only low affinity HRG binding sites. Further evidence for the unique specificity of ErbB2 in generating this high affinity binding site was determined by inhibiting HRG binding with an ErbB2 monoclonal antibody.

摘要

ErbB2作为其他ErbB受体家族成员的共享信号转导组件发挥作用。其中两种受体,即ErbB3和ErbB4,可结合神经调节蛋白(HRG)或神经调节蛋白家族的多肽生长因子。单独表达ErbB3的细胞显示出一类低亲和力的HRG结合位点,而在共表达ErbB3和ErbB2的细胞上则可检测到高亲和力和低亲和力的结合位点。为了评估ErbB受体胞外域之间的相互作用,构建了一系列可溶性同二聚体和异二聚体IgG融合蛋白。神经调节蛋白结合分析表明,由ErbB3或ErbB4与ErbB2组成的异二聚体足以形成高亲和力结合状态。相比之下,异二聚体ErbB3/4-IgG以及同二聚体ErbB3-IgG或ErbB4-IgG仅含有低亲和力的HRG结合位点。通过用ErbB2单克隆抗体抑制HRG结合,确定了ErbB2在产生这种高亲和力结合位点方面独特特异性的进一步证据。

相似文献

1
Formation of a high affinity heregulin binding site using the soluble extracellular domains of ErbB2 with ErbB3 or ErbB4.利用ErbB2与ErbB3或ErbB4的可溶性细胞外结构域形成高亲和力的神经调节蛋白结合位点。
FEBS Lett. 1998 Jul 10;431(1):102-6. doi: 10.1016/s0014-5793(98)00737-6.
2
Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin.erbB2和erbB3蛋白的共表达重建了对heregulin的高亲和力受体。
J Biol Chem. 1994 May 20;269(20):14661-5.
3
Heregulin (HRG)-induced mitogenic signaling and cytotoxic activity of a HRG/PE40 ligand toxin in human breast cancer cells.Heregulin(HRG)诱导的有丝分裂信号传导以及HRG/PE40配体毒素在人乳腺癌细胞中的细胞毒性活性。
Cell Growth Differ. 1995 Dec;6(12):1567-77.
4
A naturally occurring secreted human ErbB3 receptor isoform inhibits heregulin-stimulated activation of ErbB2, ErbB3, and ErbB4.一种天然存在的分泌型人ErbB3受体亚型可抑制神经调节蛋白刺激的ErbB2、ErbB3和ErbB4激活。
Cancer Res. 2001 Jun 1;61(11):4467-73.
5
Gamma-heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175.γ-调理性素:一种新型调理性素异构体,是人类乳腺癌细胞系MDA-MB-175的自分泌生长因子。
Oncogene. 1997 Sep 18;15(12):1385-94. doi: 10.1038/sj.onc.1201317.
6
Selection of heregulin variants having higher affinity for the ErbB3 receptor by monovalent phage display.通过单价噬菌体展示筛选对ErbB3受体具有更高亲和力的heregulin变体。
J Biol Chem. 1998 May 8;273(19):11675-84. doi: 10.1074/jbc.273.19.11675.
7
Growth regulation of human breast and ovarian tumor cells by heregulin: Evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness.Heregulin对人乳腺和卵巢肿瘤细胞生长的调节作用:证明ErbB2作为介导Heregulin反应性的关键成分的必要性。
Cancer Res. 1996 Mar 15;56(6):1457-65.
8
Binding interaction of the heregulinbeta egf domain with ErbB3 and ErbB4 receptors assessed by alanine scanning mutagenesis.通过丙氨酸扫描诱变评估神经调节蛋白β表皮生长因子结构域与ErbB3和ErbB4受体的结合相互作用。
J Biol Chem. 1998 May 8;273(19):11667-74. doi: 10.1074/jbc.273.19.11667.
9
Receptor binding and biological activity of mammalian expressed sensory and motor neuron-derived factor (SMDF).哺乳动物表达的感觉和运动神经元衍生因子(SMDF)的受体结合及生物活性
Growth Factors. 1999;16(3):241-53. doi: 10.3109/08977199909002133.
10
Heregulin stimulates mitogenesis and phosphatidylinositol 3-kinase in mouse fibroblasts transfected with erbB2/neu and erbB3.Heregulin可刺激转染了erbB2/neu和erbB3的小鼠成纤维细胞的有丝分裂及磷脂酰肌醇3激酶活性。
J Biol Chem. 1995 Mar 31;270(13):7111-6. doi: 10.1074/jbc.270.13.7111.

引用本文的文献

1
ErbB4 in the brain: Focus on high grade glioma.大脑中的表皮生长因子受体4(ErbB4):聚焦于高级别胶质瘤。
Front Oncol. 2022 Aug 31;12:983514. doi: 10.3389/fonc.2022.983514. eCollection 2022.
2
The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein.ERBB4 的阴阳两面:肿瘤抑制蛋白和癌蛋白。
Pharmacol Rev. 2022 Jan;74(1):18-47. doi: 10.1124/pharmrev.121.000381.
3
Recurrence rates in patients with HER2+ breast cancer who achieved a pathological complete response after neoadjuvant pertuzumab plus trastuzumab followed by adjuvant trastuzumab: a real-world evidence study.
曲妥珠单抗联合帕妥珠单抗新辅助治疗后 HER2+ 乳腺癌患者病理完全缓解后复发率:真实世界证据研究。
Breast Cancer Res Treat. 2021 Jun;187(3):903-913. doi: 10.1007/s10549-021-06137-3. Epub 2021 Mar 1.
4
Mammalian Expression and Biotinylation of Extracellular Protein Targets for Directed Evolution.用于定向进化的细胞外蛋白质靶点的哺乳动物表达及生物素化
ACS Omega. 2020 Sep 22;5(39):25440-25455. doi: 10.1021/acsomega.0c03990. eCollection 2020 Oct 6.
5
HER2-Positive Metastatic Breast Cancer Patients Receiving Pertuzumab in a Community Oncology Practice Setting: Treatment Patterns and Outcomes.在社区肿瘤学实践环境中接受帕妥珠单抗治疗的HER2阳性转移性乳腺癌患者:治疗模式与结局
Drugs Real World Outcomes. 2017 Mar;4(1):1-7. doi: 10.1007/s40801-016-0102-5.
6
An isoform of C/EBPβ, LIP, regulates expression of the chemokine receptor CXCR4 and modulates breast cancer cell migration.一种 C/EBPβ 的异构体 LIP 通过调节趋化因子受体 CXCR4 的表达来调节乳腺癌细胞的迁移。
J Biol Chem. 2013 Oct 4;288(40):28656-67. doi: 10.1074/jbc.M113.509505. Epub 2013 Aug 21.
7
ErbB2 dephosphorylation and anti-proliferative effects of neuregulin-1 in ErbB2-overexpressing cells; re-evaluation of their low-affinity interaction.神经调节蛋白 1 下调 ErbB2 磷酸化水平及其抗增殖作用;重新评价其低亲和力相互作用。
Sci Rep. 2013;3:1402. doi: 10.1038/srep01402.
8
Dynamically varying interactions between heregulin and ErbB proteins detected by single-molecule analysis in living cells.活细胞中单分子分析检测到的肝素结合生长因子和表皮生长因子受体蛋白之间动态变化的相互作用。
Proc Natl Acad Sci U S A. 2012 Aug 28;109(35):13984-9. doi: 10.1073/pnas.1200464109. Epub 2012 Aug 13.
9
A recombinant decoy comprising EGFR and ErbB-4 inhibits tumor growth and metastasis.一种包含 EGFR 和 ErbB-4 的重组诱饵可抑制肿瘤生长和转移。
Oncogene. 2012 Jul 26;31(30):3505-15. doi: 10.1038/onc.2011.518. Epub 2011 Nov 21.
10
Immunological Approaches in the Treatment of Metastasized Breast Cancer.转移性乳腺癌治疗中的免疫疗法
Breast Care (Basel). 2009;4(6):359-366. doi: 10.1159/000262454. Epub 2009 Dec 16.